This phenomenon could potentially contribute to the more pronounced cognitive impairments observed in female MDD patients within our study, as fluctuations in estrogen levels may exacerbate inflammation-induced IDO activation and the production of neurotoxic tryptophan catabolites. The gene discussed is IDO1; the disease is Cognitive impairment.